AMIX Autonomix Medical, Inc. - Common Stock
$6,16
Prezzo · Ago 19, 2026
Fondamentali al Ago 13, 2026
Intervallo 52 sett.
$0–$25
24% of range
Rating Analisti
BUY
8 analysts
Prezzo Obiettivo
$59
+855% upside
P/E (TTM)
—
ROE
—
Margine di Profitto Netto
—
AMIX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$6.16
Capitalizzazione di Mercato
—
P/E (TTM)
—
EPS (TTM)
—
Ricavi (TTM)
$0
Rendimento div.
—
ROE
—
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$0 – $25
AMIX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$0
2023-03-31
→
2026-03-31
EPS
—
Flusso di cassa libero
—
Margini
—
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
AMIX
Mediana dei peer
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
AMIX
Mediana dei peer
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
AMIX
Mediana dei peer
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
AMIX
Mediana dei peer
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
AMIX
Mediana dei peer
AMIX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
8 analisti
- Acquisto forte 3 37,5%
- Compra 4 50,0%
- Mantieni 1 12,5%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
2 analisti · 2026-08-16
Mediana
$58.80
← Sotto tutti i target
$6.16
Basso
$42.00
Alto
$75.60
Target mediano
$58.80
+855,3%
Target medio
$58.80
+855,3%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.33%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Dicembre 2026 | $-0.23 | $-0.27 | — |
| 31 Marzo 2026 | $-4.83 | $-5.57 | 0.74% |
| 31 Dicembre 2025 | $-7.56 | $-12.53 | 5.0% |
| 30 Settembre 2025 | $-28.98 | $-23.67 | -5.3% |
| 30 Giugno 2025 | $-22.47 | $-20.99 | -1.5% |
| 31 Marzo 2025 | $-1.81 | $-1.26 | -0.55% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| AMIX | — | — | — | — | — | — |
| CODX | $11M | -0.1 | -84.1% | -7533.6% | -151.8% | 64.3% |
| NDRA | $5M | -0.5 | — | — | -376.5% | — |
| INBS | $13M | -0.9 | -1.9% | -346.2% | -186.6% | 40.8% |
| FEED | $3M | -0.1 | -0.20% | -712.3% | -49.2% | 6.0% |
| BMRA | — | -1.4 | -1.9% | — | — | — |
| NUWE | $3M | -0.1 | -5.4% | -211.9% | 553.1% | 62.0% |
| BJDX | $403.2K | -0.0 | — | — | -121.6% | — |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 12
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | |
| R&D Expense | $7M | $5M | $2M | $745.0K | |
| SG&A Expense | $10M | $7M | $5M | $1M | |
| Operating Expenses | $17M | $12M | $12M | $2M | |
| Operating Income | $-17M | $-12M | $-12M | $-2M | |
| Interest Income | $319.0K | $354.0K | $127.0K | $0 | |
| Other Non-op | $319.0K | $178.0K | $-3M | $0 | |
| Pretax Income | $-17M | $-11M | $-15M | $-2M | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-17M | $-11M | $-15M | $-2M | |
| EPS (Basic) | $-2.32 | $-6.46 | $-14.82 | $-0.17 | |
| Shares (Basic) | 7,216,757 | 1,766,425 | 1,040,720 | 12,023,112 |
Stato Patrimoniale 18
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $9M | $9M | $865.0K | |
| Other Current Assets | $577.0K | $473.0K | $783.0K | $0 | |
| Current Assets | $8M | $10M | $9M | $865.0K | |
| PP&E (Net) | $19.0K | $21.0K | $16.0K | $0 | |
| Total Assets | $8M | $10M | $9M | $865.0K | |
| Accounts Payable | $700.0K | $676.0K | $492.0K | $173.0K | |
| Accrued Liabilities | $1M | $1M | $285.0K | $48.0K | |
| Short-term Debt | · | · | $0 | · | |
| Current Liabilities | $2M | $2M | $777.0K | $221.0K | |
| Other Non-current Liabilities | · | · | · | $0 | |
| Total Liabilities | $2M | $2M | $2M | $221.0K | |
| Long-term Debt | · | · | · | $0 | |
| Common Stock | $1.0K | $2.0K | $1.0K | $12.0K | |
| Paid-in Capital | $73M | $58M | $47M | $24M | |
| Retained Earnings | $-67M | $-50M | $-39M | $-24M | |
| Stockholders' Equity | $6M | $8M | $8M | $644.0K | |
| Liabilities + Equity | $8M | $10M | $9M | $865.0K | |
| Shares Outstanding | 542,312 | 2,497,033 | 942,575 | 12,336,571 |
Flusso di cassa 8
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| D&A | $12.0K | $183.0K | $81.0K | $0 | |
| Stock-based Comp | $529.0K | $2M | $618.0K | $0 | |
| Operating Cash Flow | $-12M | $-8M | $-7M | $-2M | |
| CapEx | $10.0K | $14.0K | $19.0K | $0 | |
| Investing Cash Flow | $-10.0K | $-14.0K | $-19.0K | $0 | |
| Stock Issued | $0 | $2.0K | $3M | $675.0K | |
| Financing Cash Flow | $10M | $9M | $14M | $675.0K | |
| Net Change in Cash | $-2M | $528.0K | $8M | $-1M |
Valutazione (TTM) 3
| Metrica | Tendenza | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | · | |
| Net Income TTM | $-17M | $-11M | $-15M | · | |
| P / Tangible Book | 0.8 | 0.5 | 149.2 | · |
Conto Economico 16
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $2M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $954.0K | $699.0K | $687.0K | $471.0K | $368.0K | |
| SG&A Expense | $1M | $1M | $2M | $5M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $793.0K | $503.0K | |
| Operating Expenses | $3M | $3M | $3M | $8M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $6M | $871.0K | |
| Operating Income | $-3M | $-3M | $-3M | $-8M | $-3M | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-6M | $-871.0K | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $33.0K | · | · | |
| Interest Income | $42.0K | $70.0K | $82.0K | $83.0K | $84.0K | $107.0K | $80.0K | $72.0K | $95.0K | $79.0K | $23.0K | $19.0K | $6.0K | |
| Other Non-op | $42.0K | $70.0K | $82.0K | $83.0K | $84.0K | $60.0K | $35.0K | $29.0K | $54.0K | $-3M | $-189.0K | $-220.0K | $6.0K | |
| Pretax Income | $-3M | $-3M | $-3M | $-7M | $-3M | $-3M | $-3M | $-3M | $-3M | $-5M | $-3M | $-6M | $-865.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-3M | $-3M | $-3M | $-7M | $-3M | $-3M | $-3M | $-3M | $-3M | $-15M | $-3M | $-6M | $-865.0K | |
| EPS (Basic) | $-5.02 | $0.49 | $-0.36 | $-1.38 | $-22.69 | $-0.53 | $-1.46 | $-2.27 | $-2.20 | $-2.90 | $-3.07 | $-8.78 | $-0.07 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | $-0.23 | · | · | |
| Shares (Basic) | 543,685 | -10,255,917 | 8,955,809 | 5,411,709 | 147,058 | -2,545,213 | 1,851,910 | 1,234,305 | 1,225,423 | -13,545,760 | 1,014,036 | 687,840 | 12,884,604 | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | · | 13,799,170 | · | · | |
| EBITDA | $-3M | · | $-3M | $-8M | $-3M | · | $-3M | $-3M | $-3M | · | $-3M | · | · |
Stato Patrimoniale 19
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $7M | $10M | $7M | $9M | $9M | $12M | $5M | $7M | $9M | $1M | · | · | |
| Other Current Assets | $504.0K | $577.0K | $257.0K | $416.0K | $389.0K | $473.0K | $109.0K | $199.0K | $325.0K | $783.0K | $467.0K | · | · | |
| Current Assets | $4M | $8M | $10M | $8M | $9M | $10M | $12M | $5M | $7M | $9M | $2M | · | · | |
| PP&E (Net) | $16.0K | $19.0K | $20.0K | $16.0K | $19.0K | $21.0K | $20.0K | $17.0K | $19.0K | $16.0K | $14.0K | · | · | |
| Total Assets | $4M | $8M | $10M | $8M | $9M | $10M | $12M | $5M | $7M | $9M | $2M | · | · | |
| Accounts Payable | $371.0K | $700.0K | $714.0K | $842.0K | $815.0K | $676.0K | $232.0K | $574.0K | $287.0K | $492.0K | $663.0K | · | · | |
| Accrued Liabilities | $447.0K | $1M | $936.0K | $645.0K | $1M | $1M | $881.0K | $683.0K | $476.0K | $285.0K | $310.0K | · | · | |
| Short-term Debt | · | · | · | · | · | · | $1M | · | · | · | · | · | · | |
| Current Liabilities | $818.0K | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $763.0K | $777.0K | $973.0K | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $5M | · | · | |
| Total Liabilities | $818.0K | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $7M | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Total Debt | · | · | · | · | · | · | $1M | · | · | · | · | · | · | |
| Common Stock | $1.0K | $11.0K | $11.0K | $6.0K | $4.0K | $2.0K | $2.0K | $1.0K | $19.0K | $1.0K | $14.0K | · | · | |
| Paid-in Capital | $73M | $73M | $73M | $68M | $61M | $58M | $57M | $48M | $47M | $47M | $28M | · | · | |
| Retained Earnings | $-70M | $-67M | $-64M | $-61M | $-54M | $-50M | $-47M | $-44M | $-42M | $-39M | $-34M | · | · | |
| Stockholders' Equity | $3M | $6M | $9M | $6M | $7M | $8M | $10M | $3M | $5M | $8M | $-6M | · | · | |
| Liabilities + Equity | $4M | $8M | $10M | $8M | $9M | $10M | $12M | $5M | $7M | $9M | $2M | · | · | |
| Shares Outstanding | 542,312 | 11,409,344 | 11,409,344 | 6,194,147 | 4,022,625 | 2,497,033 | 2,462,983 | 1,152,120 | 19,242,081 | 942,575 | 14,430,221 | · | · |
Flusso di cassa 11
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.0K | $3.0K | $4.0K | $2.0K | $3.0K | $48.0K | $47.0K | $45.0K | $43.0K | $81.0K | $35.0K | $0 | $0 | |
| Stock-based Comp | $2.0K | $1.0K | $2.0K | $138.0K | $388.0K | $405.0K | $418.0K | $445.0K | $360.0K | $618.0K | $212.0K | $151.0K | $0 | |
| Other Non-cash | $-821.0K | · | · | · | $342.0K | · | · | · | $444.0K | · | · | · | · | |
| Operating Cash Flow | $-4M | $-3M | $-3M | $-4M | $-3M | $-3M | $-2M | $-2M | $-2M | $-7M | $-3M | $-1M | $-661.0K | |
| CapEx | · | $3.0K | $7.0K | $0 | $0 | $4.0K | $5.0K | $0 | $5.0K | $19.0K | $16.0K | $0 | $0 | |
| Investing Cash Flow | · | $-3.0K | $-7.0K | $0 | $0 | $-4.0K | $-5.0K | $0 | $-5.0K | $-19.0K | $-16.0K | $0 | $0 | |
| Stock Issued | $0 | · | · | · | $2M | $2.0K | $0 | $0 | $0 | · | $0 | $0 | $3M | |
| Net Stock Activity | $0 | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $0 | $-35.0K | $5M | $3M | $2M | $-174.0K | $9M | $0 | $0 | $14M | $2M | $350.0K | $3M | |
| Net Change in Cash | $-4M | $-3M | $2M | $-1M | $-547.0K | $-3M | $7M | $-2M | $-2M | $8M | $-927.0K | $-794.0K | $2M | |
| Free Cash Flow | · | · | · | · | $-3M | · | · | · | $-2M | · | · | · | · |
Redditività 3
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -42.0% | · | -29.4% | -112.0% | -41.5% | · | -39.4% | -104.5% | -76.1% | · | -344.2% | · | · | |
| ROE | -53.5% | · | -35.7% | -157.3% | -54.2% | · | -131.9% | -185.4% | -102.1% | · | 111.3% | · | · | |
| ROIC | -87.6% | · | -39.1% | -116.9% | -48.6% | · | -25.3% | -93.7% | -52.0% | · | 52.3% | · | · |
Liquidità e Solvibilità 4
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.8 | · | 6.2 | 5.3 | 4.6 | · | 5.3 | 4.3 | 9.3 | · | 1.7 | · | · | |
| Quick Ratio | 4.2 | · | 6.0 | 5.0 | 4.4 | · | 5.3 | 4.1 | 8.8 | · | 1.3 | · | · | |
| Debt / Equity | · | · | · | · | · | · | 0.1 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -88.6 | · | · |
Efficienza 1
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · |
Valutazione (TTM) 9
| Metrica | Tendenza | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | |
| Net Income TTM | $-17M | · | $-25M | $-25M | $-20M | · | $-24M | $-24M | $-27M | · | $-11M | · | · | |
| Market Cap | $3M | · | $6M | $7M | $6M | · | $9M | $14M | $369M | · | · | · | · | |
| Enterprise Value | · | · | · | · | · | · | $-1M | · | · | · | · | · | · | |
| P/B | 1.1 | · | 0.7 | 1.0 | 0.9 | · | 1.0 | 4.6 | 69.9 | · | · | · | · | |
| P / Tangible Book | 1.1 | · | 0.7 | 1.0 | 0.9 | · | 1.0 | 4.6 | 69.9 | · | · | · | · | |
| P / Cash Flow | -1.0 | · | · | · | -2.4 | · | · | · | -199.5 | · | · | · | · | |
| P / FCF | · | · | · | · | -2.4 | · | · | · | -198.9 | · | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | 0.5 | · | · | · | · | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | |
|---|---|---|---|---|
| Ricavi | $0 | $0 | $0 | $0 |
| Utile netto | $-17M | $-11M | $-15M | $-2M |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 2 filer · $82 totale · Aggiornato al 31 Marzo 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q1 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 2 (0 vs trimestre precedente) | 3 (-1 vs trimestre precedente) | 1 (-3 vs trimestre precedente) | 4 (0 vs trimestre precedente) | +154K |
Confrontato con Q4 2025. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Investors Research Corp | $78 | 200 | 95,12% | Azioni |
| SWAN Capital LLC | $4 | 10 | 4,88% | Azioni |
Insider aziendali 1 insider · 0 dirigenti · 0 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| BioStar Ventures III, L.P. | Proprietario del 10% | 18 Giugno 2024 P | — | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Landy Toth | 26 Febbraio 2024 | — | Deposito iniziale | — | SEC |
| Walter V. Klemp | 15 Febbraio 2024 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.